Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Efficacy of a ML336 derivative against Venezuelan and eastern equine encephalitis viruses.

Jonsson CB, Cao X, Lee J, Gabbard JD, Chu YK, Fitzpatrick EA, Julander J, Chung DH, Stabenow J, Golden JE.

Antiviral Res. 2019 Jul;167:25-34. doi: 10.1016/j.antiviral.2019.04.004. Epub 2019 Apr 7.

2.

Rapid Sequencing of Multiple RNA Viruses in Their Native Form.

Wongsurawat T, Jenjaroenpun P, Taylor MK, Lee J, Tolardo AL, Parvathareddy J, Kandel S, Wadley TD, Kaewnapan B, Athipanyasilp N, Skidmore A, Chung D, Chaimayo C, Whitt M, Kantakamalakul W, Sutthent R, Horthongkham N, Ussery DW, Jonsson CB, Nookaew I.

Front Microbiol. 2019 Feb 25;10:260. doi: 10.3389/fmicb.2019.00260. eCollection 2019.

3.

Habitat, species richness and hantaviruses of sigmodontine rodents within the Interior Atlantic Forest, Paraguay.

Eastwood G, Camp JV, Chu YK, Sawyer AM, Owen RD, Cao X, Taylor MK, Valdivieso-Torres L, Sage RD, Yu A, Goodin DG, Martinez Bruyn VJ, McAllister RC, Rodriguez L, William EP, Jonsson CB.

PLoS One. 2018 Aug 1;13(8):e0201307. doi: 10.1371/journal.pone.0201307. eCollection 2018.

4.

Models of cytokine dynamics in the inflammatory response of viral zoonotic infectious diseases.

Zhang W, Jang S, Jonsson CB, Allen LJS.

Math Med Biol. 2018 Jun 29. doi: 10.1093/imammb/dqy009. [Epub ahead of print]

PMID:
29961899
5.

Natural infection of Neotropical bats with hantavirus in Brazil.

Sabino-Santos G Jr, Maia FGM, Martins RB, Gagliardi TB, Souza WM, Muylaert RL, Luna LKS, Melo DM, Cardoso RS, Barbosa NDS, Pontelli MC, Mamani-Zapana PR, Vieira TM, Melo NM, Jonsson CB, Goodin D, Salazar-Bravo J, daSilva LLP, Arruda E, Figueiredo LTM.

Sci Rep. 2018 Jun 13;8(1):9018. doi: 10.1038/s41598-018-27442-w.

6.

Rate of hepatitis C viral clearance by human livers in human patients: Liver transplantation modeling primary infection and implications for studying entry inhibition.

Hughes MG Jr, Tucker WW, Reddy S, Brier ME, Koch D, McClain CJ, Jonsson CB, Matoba N, Chung D.

PLoS One. 2017 Jul 21;12(7):e0180719. doi: 10.1371/journal.pone.0180719. eCollection 2017.

7.

A Role for Neutrophils in Viral Respiratory Disease.

Camp JV, Jonsson CB.

Front Immunol. 2017 May 12;8:550. doi: 10.3389/fimmu.2017.00550. eCollection 2017. Review.

8.

Meeting report: Tenth International Conference on Hantaviruses.

Papa A, Vaheri A, LeDuc JW, Krüger DH, Avšič-Županc T, Arikawa J, Song JW, Markotić A, Clement J, Liang M, Li D, Yashina LN, Jonsson CB, Schmaljohn CS.

Antiviral Res. 2016 Sep;133:234-41. doi: 10.1016/j.antiviral.2016.08.015. Epub 2016 Aug 17.

9.

Serologic Evidence of Mammarenaviruses among Wild Rodents in Brazil.

Sabino-Santos G Jr, Maia FG, Jonsson CB, Goodin DG, Salazar-Bravo J, Figueiredo LT.

J Wildl Dis. 2016 Jul;52(3):766-9. doi: 10.7589/2015-09-252. Epub 2016 Jun 17.

PMID:
27314481
10.

Computer-aided pulmonary image analysis in small animal models.

Xu Z, Bagci U, Mansoor A, Kramer-Marek G, Luna B, Kubler A, Dey B, Foster B, Papadakis GZ, Camp JV, Jonsson CB, Bishai WR, Jain S, Udupa JK, Mollura DJ.

Med Phys. 2015 Jul;42(7):3896-910. doi: 10.1118/1.4921618.

11.

Evidence of Hantavirus Infection Among Bats in Brazil.

Sabino-Santos G Jr, Maia FG, Vieira TM, de Lara Muylaert R, Lima SM, Gonçalves CB, Barroso PD, Melo MN, Jonsson CB, Goodin D, Salazar-Bravo J, Figueiredo LT.

Am J Trop Med Hyg. 2015 Aug;93(2):404-6. doi: 10.4269/ajtmh.15-0032. Epub 2015 Jun 15.

12.

Lower Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic Influenza A Virus Triggers Biphasic, Systemic, and Local Recruitment of Neutrophils.

Camp JV, Bagci U, Chu YK, Squier B, Fraig M, Uriarte SM, Guo H, Mollura DJ, Jonsson CB.

J Virol. 2015 Sep;89(17):8733-48. doi: 10.1128/JVI.00817-15. Epub 2015 Jun 10.

13.

Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes.

Schreiber SL, Kotz JD, Li M, Aubé J, Austin CP, Reed JC, Rosen H, White EL, Sklar LA, Lindsley CW, Alexander BR, Bittker JA, Clemons PA, de Souza A, Foley MA, Palmer M, Shamji AF, Wawer MJ, McManus O, Wu M, Zou B, Yu H, Golden JE, Schoenen FJ, Simeonov A, Jadhav A, Jackson MR, Pinkerton AB, Chung TD, Griffin PR, Cravatt BF, Hodder PS, Roush WR, Roberts E, Chung DH, Jonsson CB, Noah JW, Severson WE, Ananthan S, Edwards B, Oprea TI, Conn PJ, Hopkins CR, Wood MR, Stauffer SR, Emmitte KA; NIH Molecular Libraries Project Team.

Cell. 2015 Jun 4;161(6):1252-65. doi: 10.1016/j.cell.2015.05.023. Review.

14.

Characterization of (18)F-dipicolylamine (DPA) derivatives in cells infected with influenza virus.

Li J, Gerlach RL, Jonsson CB, Gray BD, Pak KY, Ng CK.

Nucl Med Biol. 2015 Mar;42(3):283-91. doi: 10.1016/j.nucmedbio.2014.11.012. Epub 2014 Dec 5.

PMID:
25537726
15.

Optimization of potent and selective quinazolinediones: inhibitors of respiratory syncytial virus that block RNA-dependent RNA-polymerase complex activity.

Matharu DS, Flaherty DP, Simpson DS, Schroeder CE, Chung D, Yan D, Noah JW, Jonsson CB, White EL, Aubé J, Plemper RK, Severson WE, Golden JE.

J Med Chem. 2014 Dec 26;57(24):10314-28. doi: 10.1021/jm500902x. Epub 2014 Dec 4.

16.

Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus.

Schroeder CE, Yao T, Sotsky J, Smith RA, Roy S, Chu YK, Guo H, Tower NA, Noah JW, McKellip S, Sosa M, Rasmussen L, Smith LH, White EL, Aubé J, Jonsson CB, Chung D, Golden JE.

J Med Chem. 2014 Oct 23;57(20):8608-21. doi: 10.1021/jm501203v. Epub 2014 Oct 7.

17.

Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2.

Chung DH, Jonsson CB, Tower NA, Chu YK, Sahin E, Golden JE, Noah JW, Schroeder CE, Sotsky JB, Sosa MI, Cramer DE, McKellip SN, Rasmussen L, White EL, Schmaljohn CS, Julander JG, Smith JM, Filone CM, Connor JH, Sakurai Y, Davey RA.

PLoS Pathog. 2014 Jun 26;10(6):e1004213. doi: 10.1371/journal.ppat.1004213. eCollection 2014 Jun.

18.

The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study.

Wiemken TL, Carrico RM, Klein SL, Jonsson CB, Peyrani P, Kelley RR, Aliberti S, Blasi F, Fernandez-Gonzalez R, Lopardo G, Ramirez JA; CAPO Investigators.

Vaccine. 2014 Apr 17;32(19):2198-203. doi: 10.1016/j.vaccine.2014.02.048. Epub 2014 Mar 6.

PMID:
24613522
19.

Early host responses of seasonal and pandemic influenza A viruses in primary well-differentiated human lung epithelial cells.

Gerlach RL, Camp JV, Chu YK, Jonsson CB.

PLoS One. 2013 Nov 14;8(11):e78912. doi: 10.1371/journal.pone.0078912. eCollection 2013.

20.

Ribavirin protects Syrian hamsters against lethal hantavirus pulmonary syndrome--after intranasal exposure to Andes virus.

Ogg M, Jonsson CB, Camp JV, Hooper JW.

Viruses. 2013 Nov 8;5(11):2704-20. doi: 10.3390/v5112704.

21.

The murine model for Hantaan virus-induced lethal disease shows two distinct paths in viral evolutionary trajectory with and without ribavirin treatment.

Chung DH, Västermark Å, Camp JV, McAllister R, Remold SK, Chu YK, Bruder C, Jonsson CB.

J Virol. 2013 Oct;87(20):10997-1007. doi: 10.1128/JVI.01394-13. Epub 2013 Jul 31.

22.

A computational pipeline for quantification of pulmonary infections in small animal models using serial PET-CT imaging.

Bagci U, Foster B, Miller-Jaster K, Luna B, Dey B, Bishai WR, Jonsson CB, Jain S, Mollura DJ.

EJNMMI Res. 2013 Jul 23;3(1):55. doi: 10.1186/2191-219X-3-55.

23.

Challenges and Practices in Building and Implementing Biosafety and Biosecurity Programs to Enable Basic and Translational Research with Select Agents.

Jonsson CB, Cole KS, Roy CJ, Perlin DS, Byrne G; members of the RBL-NBL Directors Network.

J Bioterror Biodef. 2013 Apr 29;Suppl 3(15):12634.

24.

Phenotypic differences in virulence and immune response in closely related clinical isolates of influenza A 2009 H1N1 pandemic viruses in mice.

Camp JV, Chu YK, Chung DH, McAllister RC, Adcock RS, Gerlach RL, Wiemken TL, Peyrani P, Ramirez JA, Summersgill JT, Jonsson CB.

PLoS One. 2013;8(2):e56602. doi: 10.1371/journal.pone.0056602. Epub 2013 Feb 18.

25.

Ferret thoracic anatomy by 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) imaging.

Wu A, Zheng H, Kraenzle J, Biller A, Vanover CD, Proctor M, Sherwood L, Steffen M, Ng C, Mollura DJ, Jonsson CB.

ILAR J. 2012;53(1):E9-21. doi: 10.1093/ilar.53.1.9.

26.

A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virus.

Chung DH, Moore BP, Matharu DS, Golden JE, Maddox C, Rasmussen L, Sosa MI, Ananthan S, White EL, Jia F, Jonsson CB, Severson WE.

Virol J. 2013 Jan 10;10:19. doi: 10.1186/1743-422X-10-19.

27.

(S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a small molecule inhibitor probe for the study of respiratory syncytial virus infection.

Moore BP, Chung DH, Matharu DS, Golden JE, Maddox C, Rasmussen L, Noah JW, Sosa MI, Ananthan S, Tower NA, White EL, Jia F, Prisinzano TE, Aubé J, Jonsson CB, Severson WE.

J Med Chem. 2012 Oct 25;55(20):8582-7. doi: 10.1021/jm300612z. Epub 2012 Oct 16.

28.

Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model.

Cameron MJ, Kelvin AA, Leon AJ, Cameron CM, Ran L, Xu L, Chu YK, Danesh A, Fang Y, Li Q, Anderson A, Couch RC, Paquette SG, Fomukong NG, Kistner O, Lauchart M, Rowe T, Harrod KS, Jonsson CB, Kelvin DJ.

PLoS One. 2012;7(9):e45842. doi: 10.1371/journal.pone.0045842. Epub 2012 Sep 24.

29.

Molecular imaging reveals a progressive pulmonary inflammation in lower airways in ferrets infected with 2009 H1N1 pandemic influenza virus.

Jonsson CB, Camp JV, Wu A, Zheng H, Kraenzle JL, Biller AE, Vanover CD, Chu YK, Ng CK, Proctor M, Sherwood L, Steffen MC, Mollura DJ.

PLoS One. 2012;7(7):e40094. doi: 10.1371/journal.pone.0040094. Epub 2012 Jul 20.

30.

Host gene expression signatures discriminate between ferrets infected with genetically similar H1N1 strains.

Ljungberg K, McBrayer A, Camp JV, Chu YK, Tapp R, Noah DL, Grimes S, Proctor ML, Liljeström P, Jonsson CB, Bruder CE.

PLoS One. 2012;7(7):e40743. doi: 10.1371/journal.pone.0040743. Epub 2012 Jul 13.

31.

Mathematical Modeling of Viral Zoonoses in Wildlife.

Allen LJ, Brown VL, Jonsson CB, Klein SL, Laverty SM, Magwedere K, Owen JC, van den Driessche P.

Nat Resour Model. 2012 Feb 1;25(1):5-51. Epub 2011 Dec 30.

32.

De-novo transcriptome sequencing of a normalized cDNA pool from influenza infected ferrets.

Camp JV, Svensson TL, McBrayer A, Jonsson CB, Liljeström P, Bruder CE.

PLoS One. 2012;7(5):e37104. doi: 10.1371/journal.pone.0037104. Epub 2012 May 11.

33.

Phylogenetic exploration of hantaviruses in Paraguay reveals reassortment and host switching in South America.

Chu YK, Owen RD, Jonsson CB.

Virol J. 2011 Aug 12;8:399. doi: 10.1186/1743-422X-8-399.

34.

A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus.

Chung DH, Ardecky R, Ganji SR, Cosford NDP, Jonsson CB, Moore BP, Jia F, Maddox C, McKellip SN, White EL, Ananthan S, Feng S, Rasmussen L, Su Y, Chung TDY, Dad S, Tower NA, Heil M.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2010 Feb 27 [updated 2010 Oct 4].

35.

Structural studies of Hantaan virus.

Battisti AJ, Chu YK, Chipman PR, Kaufmann B, Jonsson CB, Rossmann MG.

J Virol. 2011 Jan;85(2):835-41. doi: 10.1128/JVI.01847-10. Epub 2010 Nov 10.

36.

Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screen.

Maddry JA, Chen X, Jonsson CB, Ananthan S, Hobrath J, Smee DF, Noah JW, Noah D, Xu X, Jia F, Maddox C, Sosa MI, White EL, Severson WE.

J Biomol Screen. 2011 Jan;16(1):73-81. doi: 10.1177/1087057110384613. Epub 2010 Nov 8.

PMID:
21059874
37.

Early gene expression events in ferrets in response to SARS coronavirus infection versus direct interferon-alpha2b stimulation.

Danesh A, Cameron CM, León AJ, Ran L, Xu L, Fang Y, Kelvin AA, Rowe T, Chen H, Guan Y, Jonsson CB, Cameron MJ, Kelvin DJ.

Virology. 2011 Jan 5;409(1):102-12. doi: 10.1016/j.virol.2010.10.002. Epub 2010 Oct 28.

38.

Course of seasonal influenza A/Brisbane/59/07 H1N1 infection in the ferret.

McBrayer A, Camp JV, Tapp R, Yamshchikov V, Grimes S, Noah DL, Jonsson CB, Bruder CE.

Virol J. 2010 Jul 9;7:149. doi: 10.1186/1743-422X-7-149.

39.

Transcriptome sequencing and development of an expression microarray platform for the domestic ferret.

Bruder CE, Yao S, Larson F, Camp JV, Tapp R, McBrayer A, Powers N, Granda WV, Jonsson CB.

BMC Genomics. 2010 Apr 19;11:251. doi: 10.1186/1471-2164-11-251.

40.

A global perspective on hantavirus ecology, epidemiology, and disease.

Jonsson CB, Figueiredo LT, Vapalahti O.

Clin Microbiol Rev. 2010 Apr;23(2):412-41. doi: 10.1128/CMR.00062-09. Review.

41.

HTS-driven discovery of new chemotypes with West Nile Virus inhibitory activity.

Chung DH, Jonsson CB, Maddox C, McKellip SN, Moore BP, Heil M, White EL, Ananthan S, Li Q, Feng S, Rasmussen L.

Molecules. 2010 Mar 12;15(3):1690-704. doi: 10.3390/molecules15031690.

42.

Modulation of apoptosis and immune signaling pathways by the Hantaan virus nucleocapsid protein.

Ontiveros SJ, Li Q, Jonsson CB.

Virology. 2010 Jun 5;401(2):165-78. doi: 10.1016/j.virol.2010.02.018. Epub 2010 Mar 12.

43.

Sympatry of 2 hantavirus strains, paraguay, 2003-2007.

Chu YK, Goodin D, Owen RD, Koch D, Jonsson CB.

Emerg Infect Dis. 2009 Dec;15(12):1977-80. doi: 10.3201/eid1512.090338.

44.

A habitat-based model for the spread of hantavirus between reservoir and spillover species.

Allen LJ, Wesley CL, Owen RD, Goodin DG, Koch D, Jonsson CB, Chu YK, Shawn Hutchinson JM, Paige RL.

J Theor Biol. 2009 Oct 21;260(4):510-22. doi: 10.1016/j.jtbi.2009.07.009. Epub 2009 Jul 16.

45.

S. macrurus myogenic regulatory factors (MRFs) induce mammalian skeletal muscle differentiation; evidence for functional conservation of MRFs.

Kim HJ, Güth R, Jonsson CB, Unguez GA.

Int J Dev Biol. 2009;53(7):993-1002. doi: 10.1387/ijdb.082672hk.

46.

Synthesis and anti-Hantaan virus activity of N(1)-3-fluorophenyl-inosine.

Chung DH, Strouse JJ, Sun Y, Arterburn JB, Parker WB, Jonsson CB.

Antiviral Res. 2009 Jul;83(1):80-5. doi: 10.1016/j.antiviral.2009.03.007. Epub 2009 Apr 2.

47.

Microhabitat characteristics of Akodon montensis, a reservoir for hantavirus, and hantaviral seroprevalence in an Atlantic forest site in eastern Paraguay.

Goodin DG, Paige R, Owen RD, Ghimire K, Koch DE, Chu YK, Jonsson CB.

J Vector Ecol. 2009 Jun;34(1):104-13. doi: 10.1111/j.1948-7134.2009.00013.x.

48.

Bayou virus detected in non-oryzomyine rodent hosts: an assessment of habitat composition, reservoir community structure, and marsh rice rat social dynamics.

Holsomback TS, McIntyre NE, Nisbett RA, Strauss RE, Chu YK, Abuzeineh AA, de la Sancha N, Dick CW, Jonsson CB, Morris BE.

J Vector Ecol. 2009 Jun;34(1):9-21. doi: 10.1111/j.1948-7134.2009.00003.x.

49.

High-throughput screening of a 100,000-compound library for inhibitors of influenza A virus (H3N2).

Severson WE, McDowell M, Ananthan S, Chung DH, Rasmussen L, Sosa MI, White EL, Noah J, Jonsson CB.

J Biomol Screen. 2008 Oct;13(9):879-87. doi: 10.1177/1087057108323123. Epub 2008 Sep 23.

50.

Synthesis of 1-beta-D-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus.

Chung DH, Kumarapperuma SC, Sun Y, Li Q, Chu YK, Arterburn JB, Parker WB, Smith J, Spik K, Ramanathan HN, Schmaljohn CS, Jonsson CB.

Antiviral Res. 2008 Jul;79(1):19-27. doi: 10.1016/j.antiviral.2008.02.003. Epub 2008 Mar 17.

Supplemental Content

Loading ...
Support Center